Woodline Partners’s Cullinan Oncology CGEM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-81,741
| Closed | -$619K | – | 937 |
|
|
2025
Q1 | $619K | Sell |
81,741
-85,574
| -51% | -$648K | ﹤0.01% | 812 |
|
|
2024
Q4 | $2.04M | Buy |
+167,315
| New | +$2.04M | 0.01% | 645 |
|
|
2023
Q1 | – | Sell |
-195,839
| Closed | -$2.07M | – | 650 |
|
|
2022
Q4 | $2.07M | Buy |
+195,839
| New | +$2.07M | 0.03% | 466 |
|
|
2022
Q3 | – | Sell |
-818,572
| Closed | -$10.5M | – | 759 |
|
|
2022
Q2 | $10.5M | Buy |
818,572
+343,514
| +72% | +$4.4M | 0.16% | 169 |
|
|
2022
Q1 | $4.97M | Hold |
475,058
| – | – | 0.08% | 244 |
|
|
2021
Q4 | $7.33M | Hold |
475,058
| – | – | 0.11% | 240 |
|
|
2021
Q3 | $10.7M | Sell |
475,058
-86,148
| -15% | -$1.94M | 0.18% | 150 |
|
|
2021
Q2 | $14.5M | Buy |
561,206
+18,294
| +3% | +$471K | 0.27% | 100 |
|
|
2021
Q1 | $22.6M | Buy |
+542,912
| New | +$22.6M | 0.5% | 62 |
|